Amylyx Pharmaceuticals (AMLX) Stock
Amylyx Pharmaceuticals (AMLX) closed at $30.29 on Nov 13, 2026; its Tenet Score is 57 of 100 against 409 Healthcare peers.
28 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Previous close
- $30.29
- Nov 13, 2026
- Market cap
- $3.9B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 10.83 – 41.14
- low → high
- Tenet Score
- 57/100
- Mixed · 409 Healthcare peers
Industry: Drugs · see every company filed here →
Amylyx Pharmaceuticals Inc scores 57/100. Mixed. Strongest on financial health, quality is the soft spot versus 409 Healthcare peers. Insufficient inputs: Tenet 57 is built from 3 of 4 pillars, from 30% of its inputs. The pillars showing a dash had no data.
Tenet Score · vs sector
n=409Factor grades
Growth omitted — no data yet.
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Piotroski F-Score
- ~ Drawdown Context
- ~ Reversal Evidence
- ✕ Not-a-Value-Trap Gate
- ✕ Quality Floor
- ~ Qualified Dip
13F flows & insider trades land here.
Amylyx Pharmaceuticals, Inc., a biopharmaceutical company, develops therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases in the United States and Canada. The company's product candidature includes AMX0035, a dual UPR-Bax…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 13, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| CRISPR Therapeutics AGCRSP | 54 | $4.1B |
| Relay Therapeutics IncRLAY | 43 | $4.0B |
| Xenon Pharmaceuticals IncXENE | 45 | $4.0B |
| Tarsus Pharmaceuticals IncTARS | 33 | $4.0B |
| Viking Therapeutics IncVKTX | 35 | $3.7B |
| Organon & Co.OGN | 45 | $3.7B |
| Enliven Therapeutics IncELVN | 63 | $3.6B |
| Iovance Biotherapeutics IncIOVA | 52 | $3.6B |
| Arcutis Biotherapeutics IncARQT | 41 | $3.6B |
| Indivior Pharmaceuticals Inc.INDV | 51 | $3.5B |
Common questions
What sector and industry is Amylyx Pharmaceuticals in?
Amylyx Pharmaceuticals is in the Healthcare sector and the Drugs industry.
What is Amylyx Pharmaceuticals' Tenet Score?
Amylyx Pharmaceuticals' Tenet Score is 57 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.




